By URL
By Username
By MRSS
Enter a URL of an MRSS feed
 
or

Dec. 21 (Bloomberg) -- Royal DSM NV's Chief Executive Officer Feike Sijbesma talks about the agreement to buy Martek Biosciences Corp. for $1.09 billion, adding a U.S. maker of nutritional ingredients for baby food in its biggest takeover in seven years. He speaks from Amsterdam with Francine Lacqua on Bloomberg Television's "On The Move."